Fierce Pharma

APRIL 22, 2024

The prospects for Vanda Pharmaceuticals’ 10-year-old circadian rhythm drug Hetlioz have grown that much dimmer after the U.S. | The prospects for Vanda Pharmaceuticals’ 10-year-old circadian rhythm drug Hetlioz have grown that much dimmer after the U.S. Supreme Court shot down the company’s attempt to challenge an appeals court decision invalidating several of the drug’s patents in 2023.

Prospecting 278

Prospecting Pharmaceutical 278

PharmaVoice

APRIL 22, 2024

The fast-acting medication is one of a few new approaches being tested for the crippling condition.

Medical 128

Medical 128

Fierce Pharma

APRIL 22, 2024

Sanofi will pay $100 million—or approximately $25,000 each—to roughly 4,000 claimants who filed lawsuits saying that the French company failed to warn users that its heartburn medicine Zantac (rani | Sanofi will pay approximately $25,000 per person to roughly 4,000 claimants who filed lawsuits saying that the French company failed to warn users that its heartburn medicine Zantac (ranitidine) can cause cancer, Bloomberg reported.

Medicine 264

Medicine 264

MedCity News

APRIL 22, 2024

The Commonwealth Fund recently launched the National Task Force on the Future Role of Employers in the U.S. Health System. In 2025, the task force will release a blueprint of actionable recommendations on how employers can improve their coverage. The post Why the Commonwealth Fund Created a Task Force for Employer-Sponsored Insurance appeared first on MedCity News.

Insurance 118

Insurance 118

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

APRIL 22, 2024

After a merger and an FDA rejection, celebrity businessman and biotech entrepreneur Patrick Soon-Shiong’s ImmunityBio has landed the company’s first U.S. | After a merger and an FDA rejection, celebrity businessman and biotech entrepreneur Patrick Soon-Shiong’s ImmunityBio has landed the company’s first U.S. approval in the cancer immunotherapy Anktiva.

FDA 264

FDA 264

MedCity News

APRIL 22, 2024

In this episode, we’re joined by John Auerbach, senior vice president of federal health at consulting firm ICF. He discusses rising preeclampsia rates and how stakeholders need to act. The post MedCity FemFwd: What Needs To Happen to Improve Preeclampsia Rates? appeared first on MedCity News.

Consulting 117

Consulting 117

MedCity News

APRIL 22, 2024

Hospital readmissions have a two-fold impact. They not only drive up the cost of care, but they also create a glut of surplus patients in hospitals waiting to be discharged to a limited number of beds at a partner skilled nursing facility. The post Hospital Discharge Backlogs Impacting Patient Outcomes appeared first on MedCity News.

Patients 115

Patients 115

pharmaphorum

APRIL 22, 2024

Ipsen agrees $1.8 bn alliance with Skyhawk Therapeutics focused on RNA-modulating drugs for rare neurological diseases.

110

110

MedCity News

APRIL 22, 2024

Real-world analysis can provide insights into how factors largely out of rural residents’ control impact health outcomes and access to medical care. The post How Real-World Data Is Helping Close the Rural-Urban Health Divide appeared first on MedCity News.

Medical 113

Medical 113

pharmaphorum

APRIL 22, 2024

Ireland’s SynOx Therapeutics has completed a second-round financing, raising $75 million, as it prepares to take its drug for tenosynovial giant cell tumour (TGCT) into phase 3 trials. TGCT is a rare disease affecting the joints and tendons caused by overproduction of the protein CSF-1, which stimulates the proliferation of various cell types, inflammation, and destruction of the matrix of the joint.

105

105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

APRIL 22, 2024

The diagnostics/medical device track focuses on cardiology this year. The post Which Medtech Startups Will Take Part in the MedCity INVEST Pitch Perfect Contest? appeared first on MedCity News.

Medical 110

Medical 110

pharmaphorum

APRIL 22, 2024

Bristol-Myers Squibb has shored up manufacturing of its CAR-T therapies by reserving exclusive capacity wt contract manufacturer Cellares in $380m deal

Manufacturing 105

Manufacturing 105

MedCity News

APRIL 22, 2024

Two Japanese pharmaceutical companies and a bank are teaming up to form a joint venture to advance therapeutic discoveries from academia. The focus will be innovation from universities in Japan. The post Takeda, Astellas & Sumitomo Mitsui Form Joint Venture to Lift Japanese Innovation From ‘Valley of Death’ appeared first on MedCity News.

Pharmaceutical 109

Pharmaceutical Biopharma Pharma 109

Pharmaceutical Commerce

APRIL 22, 2024

The latest news for pharma industry insiders.

Pharma 103

Pharma 103

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

APRIL 22, 2024

Two months after a cyberattack on a UnitedHealth Group subsidiary halted payments to some doctors, medical providers say they’re still grappling with the fallout, even though UnitedHealth told shareholders on Tuesday that business is largely back to normal. The post Medical Providers Still Grappling With UnitedHealth Cyberattack: ‘More Devastating Than Covid’ appeared first on MedCity News.

Medical 106

Medical Doctors Physicians Healthcare 106

Pharmaceutical Technology

APRIL 22, 2024

Health Canada has approved Merck’s KEYTRUDA (pembrolizumab), an anti-programmed cell death protein 1 (PD-1) therapy for use in combination with fluoropyrimidine- and platinum-containing-chemotherapy as a first-line treatment for adult gastric cancer patients.

Patients 103

Patients 103

MedCity News

APRIL 22, 2024

The key is having a holistic approach that identifies the top two or three critical issues and tailors the primary care solution to address those needs. The post Delivering the Right Approach for Virtual Primary Care: 3 Key Insights appeared first on MedCity News.

105

105

pharmaphorum

APRIL 22, 2024

NICE backs wider NHS use of multiple myeloma drug Nexpovio Phil.

103

103

Advertisement

Pharmaceutical Commerce

APRIL 22, 2024

The rationale behind transforming case management in healthcare.

Healthcare 102

Healthcare Healthcare Management 102

MedCity News

APRIL 22, 2024

Focusing on these areas can help healthcare organizations reduce the incidence of denials, optimize revenue cycle performance and enhance overall patient satisfaction. The post Transforming Denials Management: Insights and Best Practices for Your Organization appeared first on MedCity News.

Management 100

Management Healthcare Healthcare Patients 100

Pharmaceutical Technology

APRIL 22, 2024

Discover how Avidity Biosciences' patented polynucleic acid molecule conjugate targets the DUX4 gene to combat FSHD. Learn more about this groundbreaking approach in gene therapy.

98

98

European Pharmaceutical Review

APRIL 22, 2024

The USP Microbiology Expert Committee is due to vote on the proposed Chapter <86> to approve bacterial endotoxin testing using non-animal derived reagents between 21 June and 1 July 2024. Jaap Venema , Chief Science Officer, USP shared with EPR that the chapter is helping to guide manufacturers how to the adopt these methods and provides “a path to wider adoption”.

Manufacturing 98

Manufacturing Pharmaceutical 98

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmaTimes

APRIL 22, 2024

The launch is part of the NIHRs £42m funding to establish 14 new HRCs across England

Medicine 96

Medicine 96

Pharmaceutical Technology

APRIL 22, 2024

Discover how BioMarin Pharmaceutical's patent for PAL variants offers a groundbreaking method to treat PKU in adolescents. Administering AvPAL variants weekly over 50 weeks effectively reduces blood phenylalanine levels.

Pharmaceutical 96

Pharmaceutical Patients 96

PharmaTimes

APRIL 22, 2024

The neurodegenerative condition currently affects more than 944,000 people living in the UK

93

93

MedCity News

APRIL 22, 2024

The first FDA-approved MASH drug doesn’t treat patients with liver cirrhosis. A new Boehringer Ingelheim/Ochre Bio collaboration is researching regenerative medicines that could treat patients in this most advanced stage of the fatty liver disease. The post Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases appeared first on MedCity News.

Medicine 78

Medicine FDA Patients Biopharma 78

Advertisement

Distribution

Pharmaceutical Technology

APRIL 22, 2024

Datopotamab deruxtecan is under clinical development by Daiichi Sankyo and currently in Phase I for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer).

75

75

PM360

APRIL 22, 2024

The collaboration between social media influencers and pharmaceutical companies holds promise of reshaping the future of healthcare when it comes to accurate credibility and authenticity. In recent years, the convergence of influencer marketing and the pharmaceutical industry has opened up new avenues for communication and engagement in healthcare. In an ever-evolving landscape, the intersection has emerged as a promising new frontier.

Healthcare 75

Healthcare Healthcare Media Pharmaceutical 75

Pharmaceutical Technology

APRIL 22, 2024

Datopotamab deruxtecan is under clinical development by Daiichi Sankyo and currently in Phase II for Epithelial Ovarian Cancer.

75

75

PM360

APRIL 22, 2024

An industry poised for progress will need to take the steps that reinvent copay technologies, and improve patient affordability programs. The opportunity to reshape an industry doesn’t come along every day. Two decades ago copay savings programs were once a novel idea: instant rebate cards that financially assisted millions of patients in accessing vital medications, treatments, and therapies that would otherwise be unaffordable to them.

Manufacturing 69

Manufacturing Patients Medical Pharmaceutical 69

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales